tibljТуберкулез и болезни легкихTuberculosis and Lung Diseases2075-12302542-1506Медицинские знания и технологии10.21292/2075-1230-2021-99-4-66-68tiblj-1533Research ArticleОБЗОРЫREVIEWSВыявление случаев туберкулеза и других инфекций во время пандемии COVID-19Detection of tuberculosis and other infections during the COVID-19 pandemicКандрычынС. В.KandrychynS. V.

Кандрычын Сергей Вацлавович – врач-кардиолог223041, Мінскі раён, аг. Лесной

Sergey V. Kandrychyn – Cardiologist

Ag. Lesnoy, Minsk Rayen, Belarus, 223041

Минская областная клиническая больницаБеларусьMinsk Regional Clinical HospitalBelarus2021150520219946668Copyright © Кандрычын С.В., 20212021Кандрычын С.В.Kandrychyn S.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.tibl-journal.com/jour/article/view/1533

С использованием 12 литературных источников проведено сравнение официальных данных о выявлении случаев туберкулеза и других инфекционных заболеваний в Англии и Уэльсе, Германии и Южной Корее в 2020 и 2019 г. Полученные результаты указывают, что в период пандемии COVID-19 наблюдается снижение числа выявленных случаев всех основных инфекционных заболеваний, причем при туберкулезе процент снижения меньше, чем для других инфекций.

Based on 12 publications, official data on the detection of cases of tuberculosis and other infectious diseases in England and Wales, Germany and South Korea in 2020 and 2019 were compared. The results indicate that during the COVID-19 pandemic, there is a decrease in the number of detected cases of all major infectious diseases, and the percentage of reduction in tuberculosis detection is lower versus other infections.

выявляемость туберкулезаинфекционные заболеванияCOVID-19Англия и УэльсГерманияЮжная Кореяtuberculosis detection rateinfectious diseasesCOVID-19England and WalesGermanySouth KoreaReferencesТестов В. В., Стерликов С. А., Васильева И. А., Сидорова И. А., Михайлова Ю. В. Федеральный регистр лиц, больных туберкулезом, как инструмент мониторинга влияния противоэпидемических мероприятий, вызванных пандемией COVID-19, на систему оказания противотуберкулезной помощи // Туб. и болезни легких. – 2020. – Т. 98, № 11. – С. 6-11. https://doi.org/10.21292/2075-1230-2020-98-11-6-11.Testov V.V., Sterlikov S.А., Vasilyeva I.А., Sidorova I.А., Mikhaylova Yu.V. Federal Register of TB Cases as a tool for monitoring the impact of COVID-19 pandemic response activities on the TB care system. Tuberculosis and Lung Diseases, 2020, vol. 98, no. 11, pp. 6-11. (In Russ.) https://doi.org/10.21292/2075-1230-2020-98-11-6-11.BELTA. – 2021.03.24. https://www.belta.by/regions/view/v-brestskoj-oblasti-zabolevaemost-tuberkulezom-v-2020-godu-snizilas-pochti-na-23-434171-2021/.BELTA. 2021.03.24. https://www.belta.by/regions/view/v-brestskoj-oblasti-zabolevaemost-tuberkulezom-v-2020-godu-snizilas-pochti-na-23-434171-2021/.Deutsch-Feldman M., Pratt R. H., Price S. F. et al. Tuberculosis ‒ United States, 2020 // Morb. Mortal. Wkly Rep. – 2021. – Vol. 70, № 10. – P. 409-414. DOI: http://dx.doi.org/10.15585/mmwr.mm7012a1externalicon.Deutsch-Feldman M., Pratt R.H., Price S.F. et al. Tuberculosis ‒ United States, 2020. Morb. Mortal. Wkly Rep., 2021, vol. 70, no. 10, pp. 409-414. DOI: http://dx.doi.org/10.15585/mmwr.mm7012a1externalicon.Dookie N., Padayatchi N., Naidoo K. Tuberculosis Elimination in the Era of COVID-19: A Moving Target // Clinical Infectious Diseases. – 2020. – ciaa1400. doi: 10.1093/cid/ciaa1400.Dookie N., Padayatchi N., Naidoo K. Tuberculosis Elimination in the Era of COVID-19: A Moving Target. Clinical Infection Diseases, 2020, ciaa1400. doi: 10.1093/cid/ciaa1400.Jain V. K., Iyengar K. P., Samy D. A., Vaishya R. Tuberculosis in the era of COVID-19 in India // Diabetes Metab. Syndr. – 2020. – Vol. 14, № 5. – P.1439-1443. DOI: 10.1016/j.dsx.2020.07.034.Jain V.K., Iyengar K.P., Samy D.A., Vaishya R. Tuberculosis in the era of COVID-19 in India. Diabetes Metab. Syndr., 2020, vol. 14, no. 5, Pp. 1439-1443. doi: 10.1016/j.dsx.2020.07.034.Liu Q., Lu P., Shen Y, Li C., Wang J. et al. Collateral impact of the coronavirus disease 2019 (COVID-19) pandemic on tuberculosis control in Jiangsu Province, China // Clin. Infect. Dis. – 2000. – Aug.28: ciaa1289. https:// DOI:10.1093/cid/ciaa1289.Liu Q., Lu P., Shen Y, Li C., Wang J. et al. Collateral impact of the coronavirus disease 2019 (COVID-19) pandemic on tuberculosis control in Jiangsu Province, China. Clin. Infect. Dis., 2000, Aug.28: ciaa1289. https://doi:10.1093/cid/ciaa1289.NOIDs weekly report. Statutory notification of infectious diseases in England and Wales. 2020/53 week ending. 2021.03.01. https://docviewer.yandex.by/view/23556830/?*.NOIDs weekly report. Statutory notification of infectious diseases in England and Wales. 2020/53 week ending. 2021.03.01. https://docviewer.yandex.by/view/23556830/?*.PHWR Korea disease control and prevention agency. – 2021. – Vol. 14, № 10. – P. 578. http://www.kdca.go.kr/PHWR_14_10.pdf.PHWR Korea Disease Control and Prevention Agency, 2021, vol. 14, no. 10, pp. 578. http://www.kdca.go.kr/PHWR_14_10.pdf.Robert Koch Institut. Epidemiologisches Bulletin. Aktuelle Daten und Informationen zu Infektionskrankheiten und Public Health. – 2021. – № 1. – P. 26-29. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2021/Ausgaben/01.Robert Koch Institut. Epidemiologisches Bulletin. Aktuelle Daten und Informationen zu Infektionskrankheiten und Public Health, 2021, no. 1, pp. 26-29. https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2021/Ausgaben/01.UN News. Health. – 2021.03.22. https://news.un.org/ru/story/2021/03/1399312.UN News. Health. 2021.03.22. https://news.un.org/ru/story/2021/03/1399312.UN News. Health. – 2021.03.23. https://news.un.org/ru/story/2021/03/1399502.UN News. Health. 2021.03.23. https://news.un.org/ru/story/2021/03/1399502.USAID. – 2021.03.29. https://www.usaid.gov/ru/kazakhstan/success-stories/feb-2021-combating-tb-and-covid-19.USAID. 2021.03.29. https://www.usaid.gov/ru/kazakhstan/success-stories/feb-2021-combating-tb-and-covid-19.

The authors declare that there are no conflicts of interest present.